Cargando…
Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
The recent evolution in immunosuppression therapy has led to significant improvement in short-term kidney allograft outcomes; however, this progress did not translate into similar improvement in long-term graft survival. The latter, at least in part, is likely to be attributed to immunosuppressant s...
Autores principales: | Leal, Rita, Tsapepas, Demetra, Crew, Russell J., Dube, Geoffrey K., Ratner, Lloyd, Batal, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161639/ https://www.ncbi.nlm.nih.gov/pubmed/30276344 http://dx.doi.org/10.1016/j.ekir.2017.10.010 |
Ejemplares similares
-
Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021) -
The Association Between Post–Kidney Transplant De Novo Glomerulonephritis and Alloimmunity
por: Khairallah, Pascale, et al.
Publicado: (2021) -
Oral Preconditioning of Donors After Brain Death With Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation
por: Abbasi Dezfouli, Sepehr, et al.
Publicado: (2020) -
Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
por: Helmschrott, Matthias, et al.
Publicado: (2017) -
Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zeng, Jun, et al.
Publicado: (2021)